Mylan NV Ord Shs (MYL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MYL | RDY | BBIO | ||
| Company | Mylan NV Ord Shs | Dr. Reddy's Laboratories Ltd ADR | Bridgebio Pharma Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 15.64 | 78.46 | 26.83 | ||
| High | 16.15 | 78.60 | 27.03 | ||
| Low | 15.34 | 77.96 | 26.15 | ||
| Last | 15.86 | 78.54 | 26.74 | ||
| Change | +0.31 | +0.19 | -0.09 | ||
| % Change | +1.96% | +0.24% | -0.34% | ||
| Volume | 26,574,100 | 206,346 | 2,330,700 | ||
| 20-Day Average Volume | 8,612,350 | 168,160 | 2,783,345 | ||
| Previous Close | 15.55 | 78.35 | 26.83 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 15.15 | 80.55 | 27.46 | ||
| 20-Day Raw Stochastic | 86.27% | 9.92% | 29.44% | ||
| 20-Day Relative Strength | 55.75% | 44.34% | 49.62% | ||
| Weighted Alpha | -23.10 | +17.32 | -7.87 | ||
| Today's Opinion | 40% Sell | 40% Buy | 40% Sell | ||
| Previous Opinion | 64% Sell | 40% Buy | 40% Sell | ||
| Last Month's Opinion | 64% Sell | 100% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.86% since 11/09/20 | -2.28% since 09/13/24 | +2.14% since 09/13/24 | ||
| Low | 15.10 on 11/10/20 | 77.96 on 09/20/24 | 25.80 on 09/18/24 | ||
| High | 16.15 on 11/16/20 | 80.40 on 09/16/24 | 27.68 on 09/17/24 | ||
| 1-Month | |||||
| %Chg | +0.92% since 10/16/20 | -5.58% since 08/20/24 | +4.21% since 08/20/24 | ||
| Low | 14.00 on 10/29/20 | 77.96 on 09/20/24 | 24.52 on 08/29/24 | ||
| High | 16.15 on 11/16/20 | 84.23 on 08/21/24 | 32.06 on 09/05/24 | ||
| 3-Month | |||||
| %Chg | -2.07% since 08/14/20 | +10.99% since 06/20/24 | -1.15% since 06/20/24 | ||
| Low | 14.00 on 10/29/20 | 70.72 on 06/21/24 | 21.62 on 06/24/24 | ||
| High | 17.03 on 08/19/20 | 84.46 on 08/09/24 | 32.06 on 09/05/24 | ||
| 6-Month | |||||
| %Chg | +4.58% since 05/15/20 | +7.87% since 03/20/24 | -6.60% since 03/20/24 | ||
| Low | 14.00 on 10/29/20 | 68.07 on 05/31/24 | 21.62 on 06/24/24 | ||
| High | 19.24 on 06/08/20 | 84.46 on 08/09/24 | 32.06 on 09/05/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,586,212 | 13,076,066 | 5,020,671 | ||
| Shares Outstanding, K | 541,546 | 166,893 | 187,129 | ||
| Annual Sales | 11,500,500,000 | 3,350,000,000 | 9,300,000 | ||
| Annual Net Income | 16,800,000 | 668,000,000 | -643,200,000 | ||
| Last Quarter Sales | 2,972,100,000 | 921,000,000 | 2,170,000 | ||
| Last Quarter Net Income | 185,700,000 | 167,000,000 | -73,460,000 | ||
| 60-Month Beta | 1.45 | 0.55 | 1.07 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.36 on 11/06/20 | 1.00 on 07/27/24 | -1.02 on 08/01/24 | ||
| Latest Earnings Date | 11/06/20 | 10/25/24 | 11/07/24 | ||
| Most Recent Dividend | 0.060 on 06/27/07 | 0.404 on 07/30/24 | N/A | ||
| Next Ex-Dividends Date | N/A | 07/30/24 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 3.29 | 19.70 | 0.00 | ||